Pfizer, Starboard and Albert Bourla
Pfizer’s CEO reflects on a year of discovery and what he thinks critics get wrong about vaccine pricing Albert Bourla talks about his employees' effort to develop a COVID-19 vaccine in record ...
Activist investor Starboard Value has acquired a significant stake in Pfizer, valued at around $1 billion, as it aims to ...
Pfizer's ex-chair and chief executive Ian Read and Frank D'Amelio – previously the drugmaker's finance chief – have issued a ...
The European Commission president is suspected of withholding private text messages that she supposedly exchanged with the CEO of Pfizer T ...